Attend an industry expert session at Summer Meeting

Industry expert sessions are the newest addition to the Academy exhibit hall. They will be presented on the Purple Level, Riverside Center at the Hyatt Regency.

These unique sessions provide exhibiting companies the opportunity to:

  • Present new research findings on products
  • Detail products
  • Conduct demonstrations
  • Highlight new products

These sessions are solely promotional and are not eligible for continuing medical education credit.

Friday

11:30 a.m. to 12:15 p.m.: “A Treatment Option for Certain Patients with Chronic Idiopathic Urticaria,” hosted by Genentech/Novartis

The goal of this event is to educate dermatologists on a treatment option for certain patients with chronic idiopathic urticaria. Steven R. Feldman, MD, PhD, director of the Department of Dermatology at Wake Forest University School of Medicine, will be the speaker. The content will consist of an understanding of chronic idiopathic urticaria as well as information about a treatment option.

12:45 – 1:35 p.m.: “Clinical Pearls in Psoriasis: Advancing Doctor-Patient Dialogue,” hosted by Novartis Pharmaceutical

The session will provide a better understanding of:

  • The evolving immunopathogenesis of psoriasis
  • The role of the different immune cells and their cytokines, including IL-17A, in the pathogenesis of psoriasis
  • The patient’s perspective on the impact of psoriasis (leverage learning from the Patient Listening Project)
  • The physical and emotional impacts of psoriasis and how they affect important lifestyle issues (e.g., intimacy, occupation, sleep)
  • The importance of patient-physician communication in optimizing patient care and enhancing patient satisfaction

Saturday

11:30 a.m. – 12:15 p.m.: “Topical Antifungal Therapy:  New Options, New Opportunities,” hosted by Valeant Pharmaceuticals NA

Learn about the safety and effectiveness of two new topical anti-fungal therapies for the treatment of tinea pedis, tinea cruris, tinea corporis, and onychomycosis from an esteemed faculty presenter.

12:45 – 1:35 p.m.: “A New Oral Treatment for Adult Patients with Active Psoriatic Arthritis,” hosted by Celgene Corporation

This session will review unmet needs and pathophysiology of psoriatic arthritis as well as the clinical data and mechanism of action of a new treatment option for psoriatic arthritis.

Return to index

Top